Medical articles today

/* 728x15, */

2010 National Evacuation Conference

Retired Gen. Russel HonorĂ, who served as commander of Joint Task Force Katrina, will headline an impressive lineup of keynote speakers and panelists set to appear as part of the 2010 National Evacuation Conference. The conference will be held Feb. 3-5at the JW Marriott in New Orleans, La., and is being organized by the Stephenson Disaster Management Institute, or SDMI, and the Gulf Coast Research Center for Evacuation and Transportation Resiliency, which is housed at both LSU and the University of New Orleans. "The recent earthquake in Haiti reminds us all again of the critical nature of this work, " said SDMI Interim Executive Director Thomas Anderson.

Dogs May Provide An Excellent Model For Understanding Human Complex Diseases

In the new Swedish-Finnish study, published in Nature Genetics, the researchers identified five loci that predispose to an SLE-related disease in Nova Scotia duck tolling retrievers. The study indicates that the homogeneity of strong genetic risk factors within dog breeds make dogs an excellent model in which to identify pathways involved in human complex diseases. The results of the study also open the door for further studies of specific T-cell activation pathways in human populations. The unique canine breed structure makes dogs an excellent model for studying genetic diseases. Incidences of specific diseases are elevated in different breeds, indicating that a few genetic risk factors might have accumulated through drift or selective breeding.

/* 468x60, */

AVMA Seeks Member Input To Shape Strategic Plan

The American Veterinary Medical Association (AVMA) is asking for input from its members to help shape the future of the association and the profession. The AVMA is initiating this "Future Critical Issues Scan" as part of its ongoing effort to reevaluate and revise its strategic plan, which was last approved by the AVMA Executive Board in April 2008. The AVMA hopes this scan will produce feedback from all segments of its diverse membership, which encompasses more than 80, 000 veterinarians in private practice, government, industry, academia, research and uniformed services. "The input and active participation of our membership has gotten us to the strong position we are in today, " said Dr.

BVA And BSAVA Welcome Scotland's Move To Control Dangerous Dogs

The British Veterinary Association (BVA) and British Small Animal Veterinary Association (BSAVA) have welcomed the Scottish Parliament's vote at the first stage of the Control of Dogs (Scotland) Bill which will place a legislative focus on the deed, rather than the breed of dogs and hold dog owners to account. The Bill received cross-party support when MSPs voted in favour of the proposals yesterday (10 February), which would offer a flexible range of Control Orders providing practical measures to stop dogs getting out of control and place the focus on the owner. The BVA has long been opposed to any proposals which single out particular breeds of dogs rather than targeting individual aggressive dogs.

BioCurex Announces Commercialization Of OncoPet RECAFTM, The First Blood Test For Cancer Detection In Companion Animals

BioCurex Inc. (OTCBB:BOCX), a biotechnology company developing products based on patented technology in the areas of cancer diagnostics, announced that it has launched the commercialization of its OncoPet RECAF test for cancer detection in dogs. The test detected 85 percent of a variety of cancers in dogs, at the standard 95 percent specificity level in pre-market studies. The Company believes that this launch represents the first commercialization of a blood-based test for the universal detection of cancer in companion animals. The test detects the presence of RECAF, a universal marker for malignant cell growth in humans and animals. BioCurex developed and patented the RECAF technology for cancer applications.

/* 468x60, */

Histostem Participates In Successful Stem Cell Treatment For Acute Spinal Cord Injury In Dogs

Stem Cell Therapy International, Inc. (OTCBB: SCII) announced that Histostem Ltd. of South Korea ("Histostem") has participated in a study resulting in the successful treatment of spinal cord injury in dogs through the use of Multipotent Stem Cells (MSCs) derived from Human Umbilical Cord Blood (HUCB). The study, a collaborative effort between a team of doctors from the Departments of Veterinary Surgery and Veterinary Anatomy at Konkuk University, Seoul, Korea and Dr. Hoon Han, President and Founder of Histostem, presented a method for the percutaneous transplantation of stem cells and investigated the therapeutic efficacy of transplanting stem cells to improve the recovery of the central nervous system following such acute spinal cord injury.

/* 160x600, */
Medical articles today © Padayatra Dmitriy
Designer Dimitrov Dmytriy